Massively parallel sequencing of micro-manipulated cells targeting a comprehensive panel of disease-causing genes: A comparative evaluation of upstream whole-genome amplification methods

Autor: Yannick Gansemans, Filip Van Nieuwerburgh, Lieselot Deleye, Dieter De Coninck, Dieter Deforce
Rok vydání: 2018
Předmět:
0301 basic medicine
Male
lcsh:Medicine
Gene Sequencing
Genome
Polymerase Chain Reaction
Database and Informatics Methods
0302 clinical medicine
Genomic library
DNA sequencing
Genome Sequencing
lcsh:Science
Whole Genome Amplification
030219 obstetrics & reproductive medicine
Multidisciplinary
Massive parallel sequencing
High-Throughput Nucleotide Sequencing
Genomics
Gene Pool
Neoplastic Cells
Circulating

ALIGNMENT
Single-Cell Analysis
Nucleic Acid Amplification Techniques
Sequence Analysis
Research Article
Genotyping
DNA Copy Number Variations
Genotype
Bioinformatics
Nucleotide Sequencing
Computational biology
Biology
ABERRATIONS
Research and Analysis Methods
Polymorphism
Single Nucleotide

Cell Line
Molecular Genetics
EMBRYOS
03 medical and health sciences
Genetics
Humans
Molecular Biology Techniques
Sequencing Techniques
Molecular Biology
Gene Library
Evolutionary Biology
Population Biology
ANEUPLOIDY
Genome
Human

lcsh:R
Biology and Life Sciences
Computational Biology
Nucleic acid amplification technique
DNA
Sequence Analysis
DNA

Genome Analysis
Genomic Libraries
030104 developmental biology
Human genome
lcsh:Q
Sequence Alignment
Population Genetics
GENERATION
Zdroj: PLoS ONE
PLoS ONE, Vol 13, Iss 4, p e0196334 (2018)
PLOS ONE
ISSN: 1932-6203
Popis: Single Gene Disorders (SGD) are still routinely diagnosed using PCR-based assays that need to be developed and validated for each individual disease-specific gene fragment. The TruSight One sequencing panel currently covers 12 Mb of genomic content, including 4813 genes associated with a clinical phenotype. When only a limited number of cells are available, whole genome amplification (WGA) is required prior to DNA target capture techniques such as the TruSight One panel. In this study, we compared 4 different WGA methods in combination with the TruSight One sequencing panel to perform single nucleotide polymorphism (SNP) genotyping starting from 3 micro-manipulated cells. This setting simulates clinical settings such as day-5 blastocyst biopsy for Preimplantation Genetic Testing (PGT), liquid biopsy of circulating tumor cells (CTCs) and cancer-cell profiling. Bulk cell samples were processed alongside these WGA samples to serve as a performance reference. Target coverage, coverage uniformity and SNP calling accuracy obtained using any of the WGA, is inferior to the results obtained on bulk cell samples. However, results after REPLI-g come close. Compared to the other WGA methods, the method using REPLI-g WGA results in a better coverage of the targeted genomic regions with a more uniform read depth. Consequently, this method also results in a more accurate SNP calling and could be considered for clinical genotyping of a limited number of cells.
Databáze: OpenAIRE
Nepřihlášeným uživatelům se plný text nezobrazuje